Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Cardiff Oncology Inc. (CRDF)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
VenBio Select Advisor

Kurt Von Emster

1,000,000 $5,010 0.09%
2.
Opaleye Management

James A. Silverman

590,000 $2,956 0.59%
3. 407,500 $2,042 0.58%
4. 268,800 $1,347 0%
5.
Corriente Advisors

Mark Hart Iii

173,361 $869 0.56%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$5.71 850 Director 450,311 2020-09-16 Filing
$5.69 1,700 Director 449,461 2020-09-16 Filing
$1.43 6,993 Officer 13,369 2020-05-14 Filing
$1.43 20,979 Director 28,160 2020-05-14 Filing
$1.43 6,993 Director 9,260 2020-05-14 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$0.69 8,334 Director 209,394 2017-09-05 Filing
$8.64 4,200 Director 326,486 2013-09-03 Filing
$8.06 15,000 Director 330,686 2013-08-30 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 1,595,164 $7,992 8.43%
2. 294,376 $1,475 0%
3. 135,650 $680 0.01%
4. 96,400 $483 0.04%
5. 36,950 $185 0.09%